Repligen Corp
Biological Products, (No Diagnostic Substances) · Waltham, MA, United States
- PrincipalsBrian Robb DouglassCHIEF PRODUCT OFFICERJames BylundChief Operating OfficerJason K GarlandCFOand 5 more
- CompanyRepligen CorpWaltham, MA, United States
- Phone line+1 (781) 449-9560General business
Repligen Corp is an SEC-registered Nasdaq-listed company (ticker RGEN) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 8
Chief executive
Olivier LoeillotChief Executive Officer
Finance
Operations
James BylundChief Operating Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗James Bylund — Chief Operating Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jason K Garland — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Olivier Loeillot — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Brian Robb Douglass — CHIEF PRODUCT OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pl. VIIPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityPl. VIIenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityPl. VIIAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPl. VIICrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityPl. VIIEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPl. VIIMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityPl. VIIRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityPl. VIIDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capability